Skip to content
1887

Abstract

Host genetics plays a pivotal role in determining disease susceptibility among individuals infected with . Scavenger receptors (SRs) such as and mediate pathogen recognition and lipid uptake, both of which are central to mycobacterial entry and immune modulation.

Polymorphisms rs1761667 and rs3211938 in and rs4238001 in have not been investigated in any population in relation to both latent tuberculosis infection (LTBI) and active tuberculosis (TB).

To genotype and polymorphisms and evaluate their association with TB and LTBI. To predict the functional/regulatory impact of these SNPs and compare their allele frequencies with global datasets.

Polymorphisms were genotyped using amplification refractory mutation system PCR within a case-control design. Genotype frequencies were compared using Fisher’s exact chi-square test. Functional and regulatory effects were predicted using PolyPhen-2 and RegulomeDB, while the 1000 Genomes database was used for population comparison.

The homozygous AA genotype of rs4238001 was strongly associated with active TB (=0.00), while the heterozygous GA genotype showed a protective association with LTBI (=0.00). For , the homozygous GG genotype of rs3211938 was associated with protection against active TB (=0.02) but exhibited the opposite pattern in LTBI (<0.00). Moreover, the heterozygous GA genotype of rs1761667 was significantly linked to increased risk of LTBI (=0.00). functional prediction classified rs4238001 as missense and rs3211938 as nonsense variant. Regulatory analysis indicated that rs4238001 and rs1761667 affect transcription in TB-relevant tissues. Population analysis highlighted variation in allele frequencies across groups.

Polymorphisms in and show distinct associations with LTBI and TB, suggesting contrasting genetic influences on infection establishment and disease onset. These findings reveal a novel host genetic component of TB pathogenesis and warrant validation in larger, multiethnic cohorts.

Funding
This study was supported by the:
  • National University of Medical Sciences, Rawalpindi, Pakistan
    • Principal Award Recipient: SidraYounis
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.002111
2025-12-18
2026-01-16

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/12/jmm002111.html?itemId=/content/journal/jmm/10.1099/jmm.0.002111&mimeType=html&fmt=ahah

References

  1. Colangeli R, Gupta A, Vinhas SA, Chippada Venkata UD, Kim S et al. Mycobacterium tuberculosis progresses through two phases of latent infection in humans. Nat Commun 2020; 11:4870 [View Article] [PubMed]
    [Google Scholar]
  2. World Health Organization Global tuberculosis report 2025; 2025 https://www.who.int/publications/i/item/9789240116924 accessed 18 November 2025
  3. National Institutes of Health Pakistan National TB control program; 2020 https://www.nih.org.pk/national-tb-control-program accessed 29 July 2025
  4. O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ et al. The immune response in tuberculosis. Annu Rev Immunol 2013; 31:475–527 [View Article] [PubMed]
    [Google Scholar]
  5. Fortin A, Abel L, Casanova JL, Gros P. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu Rev Genomics Hum Genet 2007; 8:163–192 [View Article] [PubMed]
    [Google Scholar]
  6. Apt A, Kramnik I. Man and mouse TB: contradictions and solutions. Tuberculosis 2009; 89:195–198 [View Article] [PubMed]
    [Google Scholar]
  7. Peiser L, Gordon S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect 2001; 3:149–159 [View Article] [PubMed]
    [Google Scholar]
  8. Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr 2019; 7: [View Article]
    [Google Scholar]
  9. Tariq EB, Subhan U, Deeba F, Younis S. Tuberculosis and scavenger receptors: exploring their relationship. JSTMU 2024; 6:113–121 [View Article]
    [Google Scholar]
  10. Bowdish DME, Sakamoto K, Kim M-J, Kroos M, Mukhopadhyay S et al. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 2009; 5:e1000474 [View Article] [PubMed]
    [Google Scholar]
  11. Ramos-Lopez O, Roman S, Martinez-Lopez E, Fierro NA, Gonzalez-Aldaco K et al. CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection. World J Hepatol 2016; 8:1067–1074 [View Article] [PubMed]
    [Google Scholar]
  12. Fry AE, Ghansa A, Small KS, Palma A, Auburn S et al. Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet 2009; 18:2683–2692 [View Article] [PubMed]
    [Google Scholar]
  13. Ma R, Zhu X, Yan B. SCARB1 rs5888 gene polymorphisms in coronary heart disease: a systematic review and a meta-analysis. Gene 2018; 678:280–287 [View Article] [PubMed]
    [Google Scholar]
  14. Juárez-Meavepeña M, Carreón-Torres E, López-Osorio C, García-Sánchez C, Gamboa R et al. The Srb1+1050T allele is associated with metabolic syndrome in children but not with cholesteryl ester plasma concentrations of high-density lipoprotein subclasses. Metab Syndr Relat Disord 2012; 10:110–116 [View Article] [PubMed]
    [Google Scholar]
  15. Gautam S, Agrawal CG, Banerjee M. CD36 gene variants in early prediction of type 2 diabetes mellitus. Genet Test Mol Biomarkers 2015; 19:144–149 [View Article] [PubMed]
    [Google Scholar]
  16. Martín-Márquez BT, Sandoval-Garcia F, Vazquez-Del Mercado M, Martínez-García E-A, Corona-Meraz F-I et al. Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican mestizos with type-2 diabetes from western Mexico. Nutr Hosp 2021; 38:742–748 [View Article] [PubMed]
    [Google Scholar]
  17. Šerý O, Zeman T, Sheardová K, Vyhnálek M, Marková H et al. Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer’s disease. Sci Rep 2022; 12:10994 [View Article] [PubMed]
    [Google Scholar]
  18. West M, Greason E, Kolmakova A, Jahangiri A, Asztalos B et al. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab 2009; 94:1451–1457 [View Article] [PubMed]
    [Google Scholar]
  19. Love-Gregory L, Sherva R, Schappe T, Qi J-S, McCrea J et al. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet 2011; 20:193–201 [View Article] [PubMed]
    [Google Scholar]
  20. Ma M-J, Wang H-B, Li H, Yang J-H, Yan Y et al. Genetic variants in MARCO are associated with the susceptibility to pulmonary tuberculosis in Chinese Han population. PLoS One 2011; 6:e24069 [View Article] [PubMed]
    [Google Scholar]
  21. Bowdish DM, Sakamoto K, Lack NA, Hill PC, Sirugo G et al. Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population. BMC Med Genet 2013; 14:47 [View Article] [PubMed]
    [Google Scholar]
  22. Lao W, Kang H, Jin G, Chen L, Chu Y et al. Evaluation of the relationship between MARCO and CD36 single-nucleotide polymorphisms and susceptibility to pulmonary tuberculosis in a Chinese Han population. BMC Infect Dis 2017; 17:488 [View Article] [PubMed]
    [Google Scholar]
  23. Wang J, Cao H, Yang H, Wang N, Weng Y et al. The function of CD36 in Mycobacterium tuberculosis infection. Front Immunol 2024; 15:1413947 [View Article]
    [Google Scholar]
  24. Dodd CE, Pyle CJ, Glowinski R, Rajaram MVS, Schlesinger LS. CD36-mediated uptake of surfactant lipids by human macrophages promotes intracellular growth of Mycobacterium tuberculosis. J Immunol 2016; 197:4727–4735 [View Article] [PubMed]
    [Google Scholar]
  25. Hawkes M, Li X, Crockett M, Diassiti A, Finney C et al. CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect Dis 2010; 10:299 [View Article] [PubMed]
    [Google Scholar]
  26. Il’in DA, Shkurupy VA. In vitro analysis of the expression of CD11, CD29, CD36, and DC-STAMP molecules during the formation of multinuclear macrophages in BCG-infected mice. Bull Exp Biol Med 2019; 167:653–655 [View Article] [PubMed]
    [Google Scholar]
  27. Almeida PE de, Pereira de Sousa NM, Rampinelli PG, Silva RV de S, Correa JR et al. Lipid droplets as multifunctional organelles related to the mechanism of evasion during mycobacterial infection. Front Cell Infect Microbiol 2023; 13:1102643 [View Article]
    [Google Scholar]
  28. Chang S-Y, Chen M-L, Lee M-R, Liang Y-C, Lu T-P et al. SP110 polymorphisms are genetic markers for vulnerability to latent and active tuberculosis infection in Taiwan. Dis Markers 2018; 2018:4687380 [View Article] [PubMed]
    [Google Scholar]
  29. Chu Y, Lao W, Jin G, Dai D, Chen L et al. Evaluation of the relationship between CD36 and MARCO single-nucleotide polymorphisms and susceptibility to carotid atherosclerosis in a Chinese Han population. Gene 2017; 633:66–70 [View Article] [PubMed]
    [Google Scholar]
  30. Zhang Y, Ling ZY, Deng SB, Du HA, Yin YH et al. Associations between CD36 gene polymorphisms and susceptibility to coronary artery heart disease. Braz J Med Biol Res 2014; 47:895–903 [View Article] [PubMed]
    [Google Scholar]
  31. Józefowski S, Sobota A, Pawłowski A, Kwiatkowska K. Mycobacterium tuberculosis lipoarabinomannan enhances LPS-induced TNF-α production and inhibits NO secretion by engaging scavenger receptors. Microb Pathog 2011; 50:350–359 [View Article] [PubMed]
    [Google Scholar]
  32. Sattler N, Bosmani C, Barisch C, Guého A, Gopaldass N et al. Functions of the Dictyostelium LIMP-2 and CD36 homologues in bacteria uptake, phagolysosome biogenesis and host cell defence. J Cell Sci 2018; 131:jcs218040 [View Article] [PubMed]
    [Google Scholar]
  33. AlSaeed H, Haider MJA, Alzaid F, Al-Mulla F, Ahmad R et al. PPARdelta: a key modulator in the pathogenesis of diabetes mellitus and Mycobacterium tuberculosis co-morbidity. iScience 2024; 27:110046 [View Article] [PubMed]
    [Google Scholar]
  34. Khan A, Mann L, Papanna R, Lyu M-A, Singh CR et al. Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy. Sci Rep 2017; 7:15010 [View Article] [PubMed]
    [Google Scholar]
  35. Alkazmi L, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M et al. The potential role of scavenger receptor B type I (SR-BI) in SARS-CoV-2 infection. Immun Inflamm Dis 2023; 11:e786 [View Article] [PubMed]
    [Google Scholar]
  36. Manichaikul A, Wang X-Q, Musani SK, Herrington DM, Post WS et al. Association of the lipoprotein receptor SCARB1 common missense variant rs4238001 with incident coronary heart disease. PLoS One 2015; 10:e0125497 [View Article] [PubMed]
    [Google Scholar]
  37. Yates M, Kolmakova A, Zhao Y, Rodriguez A. Clinical impact of scavenger receptor class B type I gene polymorphisms on human female fertility. Hum Reprod 2011; 26:1910–1916 [View Article] [PubMed]
    [Google Scholar]
  38. Khan HS, Nair VR, Ruhl CR, Alvarez-Arguedas S, Galvan Rendiz JL et al. Identification of scavenger receptor B1 as the airway microfold cell receptor for Mycobacterium tuberculosis. Elife 2020; 9:e52551 [View Article] [PubMed]
    [Google Scholar]
  39. Schäfer G, Guler R, Murray G, Brombacher F, Brown GD. The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model. PLoS One 2009; 4:e8448 [View Article] [PubMed]
    [Google Scholar]
  40. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999; 19:1734–1743 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.002111
Loading
/content/journal/jmm/10.1099/jmm.0.002111
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error